Home > SANTE - SCIENCES DE LA VIE > Industrie Pharmaceutique > Médicaments En Vente Libre > Bausch & Lomb Incorporated - ...
AUTRES RESSOURCES
 
AUTRES SECTEURS
 
TOUS NOS SECTEURS
 
Médicaments En Vente Libre > Etude de marché sectorielle
 Bausch & Lomb Incorporated - SWOT Analysis
€ 100,00
Editeur :
Datamonitor
Langue :
Anglais
Date de publication :
Mai 2007
Taille du document :
28
Autres informations :
Description , Table des matières
 
Recevez cette publication aujourd'hui !
Plus d'information ?
+33 437 37 1637
 
Rechercher d'autres rapports et études à commander

Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux


Rapports privés en relation
US Lip Remedies 2004
13 pages | Juillet 2004 |
Snapdata's US Lip Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US lip remedy market, and covers
240,00 €
 
 
US Contraceptives 2004
12 pages | Novembre 2004 |
Snapdata's US Contraceptives 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US contraceptive market, and co
240,00 €
 
 
US Foot Care Products 2004
13 pages | Juillet 2004 |
Snapdata's US Foot Care Products 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US foot care product market
240,00 €
 
 
US Sleeping Remedies 2004
12 pages | Novembre 2004 |
Snapdata's US Sleeping Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US sleeping remedy market.
240,00 €
 
 
UK Hayfever Remedies 2004
13 pages | Juillet 2004 |
Snapdata's UK Hayfever Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the UK hayfever remedy market, a
240,00 €
 
 
The Biogenerics Market Outlook: An analysis of market dynamics, growth drivers and leading players
87 pages | Mars 2005 |
Branded biologic medicines generated an estimated $32bn of sales for the biotechnology and pharmaceutical industries and represented the fastest growing group of medicines; while continued high demand
2 443,75 €
 
 
The Biogenerics Market Outlook: An analysis of market dynamics, growth drivers and leading players
87 pages | Mars 2005 |
Branded biologic medicines generated an estimated $32bn of sales for the biotechnology and pharmaceutical industries and represented the fastest growing group of medicines; while continued high demand
1 520,00 €
 
 
Chinese Markets for OTC Drugs
220 pages | Février 2002 |
China's demand for OTC drugs has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's economic trend
2 835,00 €
 
 
US Cough Syrup 2004
12 pages | Juillet 2004 |
Snapdata's US Cough Syrup 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US cough syrup market, and covers
240,00 €
 
 
US Mineral Supplements 2004
12 pages | Novembre 2004 |
Snapdata's US Mineral Supplements 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US mineral supplement mark
240,00 €
 
 
 
Autres secteurs en relation
Rechercher d'autres rapports!
 
 
 
Présentation de l'étude de marché - Description & Table des matières
 Bausch & Lomb Incorporated - SWOT Analysis

Datamonitor's Bausch & Lomb Incorporated - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Bausch & Lomb is engaged in the development, manufacture and marketing of eye health products, including contact lenses, lens care products and ophthalmic pharmaceuticals. The company operates in more than 100 countries across the Americas, Europe, Middle East and Africa, and Asia. It is headquartered in Rochester, New York and employs about 13,000 people. The company recorded revenues of $2,292.4 million during the fiscal year ended December 2006, a decrease of 2.6% over 2005. The operating profit of the company was $114 million during fiscal year 2006, a decrease of 59.8% over 2005. The net profit was $14.9 million in fiscal year 2006, a decrease of 22.4% over 2005.

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available


 

Table of Contents:
This product typically includes the following sections:

Key Facts
Company Overview
Business Description
Company History
Key Employees
Key Employee Biographies
Company View
SWOT analysis
Products & Services Listing
Products & Services Analysis


New Search:

PPLSEN